Surefire Precision gains FDA 510(k) clearance twice as fast as the industry average with T3 Labs
Surefire Medical achieves FDA 510(k) clearance for direct-to-tumor embolization device Surefire Precision in just 76 days with the help of T3 Labs.
GCMI Atlanta – Pre Clinical CRO
Successfully guiding medtech innovation
